Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

OTCPK:SHEZ.F Stock Report

Market Cap: US$2.1b

Shenzhen Hepalink Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:SHEZ.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Jun 24BuyUS$190,634Zejun HongIndividual452,500US$0.42
05 Jun 24BuyUS$95,081Zejun HongIndividual210,000US$0.45
20 May 24BuyUS$218,670Zejun HongIndividual460,000US$0.48

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SHEZ.F?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme19,004,2991.3%
Individual Insiders24,030,0001.64%
Institutions34,280,2042.34%
General Public421,164,92228.7%
Private Companies968,816,77966%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 71.26% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
32.3%
Shenzhen Leren Scientific & Technological Co., Ltd.
474,029,899US$664.1m0%no data
27.8%
Xiamen Jintiantu Investment Partnership Enterprise (Limited Partnership)
408,041,280US$571.7m0%no data
3.16%
Xiamen Shuidi Shichuan Investment Partnership Enterprise (Limited Partnership)
46,425,600US$65.0m0%no data
2.75%
Xiamen Feilaishi Investment Co., Ltd.
40,320,000US$56.5m0%no data
1.64%
Zejun Hong
24,030,000US$33.7m179%no data
1.3%
Shenzhen Hepalink Pharmaceutical Co.,Ltd., ESOP
19,004,299US$26.6m0%no data
0.86%
AVICT Global Holdings Limited
12,629,500US$17.7m0%100.0%
0.41%
Morgan Stanley, Investment Banking and Brokerage Investments
6,020,983US$8.4m0%no data
0.23%
The Vanguard Group, Inc.
3,426,518US$4.8m4.59%no data
0.19%
China Southern Asset Management Co., Ltd.
2,718,799US$3.8m0%0.01%
0.086%
Polunin Capital Partners Limited
1,257,889US$1.8m0%0.17%
0.081%
Dimensional Fund Advisors LP
1,192,500US$1.7m9.8%no data
0.074%
Fullgoal Fund Management Co. Ltd.
1,090,800US$1.5m0%no data
0.069%
Invesco Great Wall Fund Management Co. Ltd
1,012,200US$1.4m0%0.01%
0.051%
China Universal Asset Management Company Ltd.
748,000US$1.0m-9.81%no data
0.049%
Shanghai Guotai Junan Securities Asset Management Co., Ltd.
714,692US$1.0m2,000%0.03%
0.036%
Great Wall Fund Management Co., Ltd
535,400US$750.1k0%0.02%
0.035%
Taiping Fund Management Company Ltd.
508,500US$712.5k0%0.08%
0.026%
E Fund Management Co., Ltd.
384,188US$538.2k-94%no data
0.023%
State Street Global Advisors, Inc.
332,000US$465.2k1.47%no data
0.02%
JP Morgan Asset Management
287,460US$402.7k0%no data
0.017%
Western Leadbank Fund Management Co., Ltd.
251,062US$351.7k-6.77%0.02%
0.016%
HuaAn Fund Management Company Ltd.
231,600US$324.4k0%no data
0.016%
CICC Fund Management Co., Ltd.
231,600US$324.4k0%0.1%
0.011%
Gfund Management Co., Ltd.
161,900US$226.7k0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/11 22:54
End of Day Share Price 2024/07/15 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lei TianAJ Securities Co., Ltd
Peng YanChangjiang Securities Co. LTD.
Diandian LiChina Merchants Securities Co. Ltd.